-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on Clover Health Investments, Lowers Price Target to $3.7

Benzinga·11/06/2025 19:56:51
Listen to the news
Canaccord Genuity analyst Richard Close maintains Clover Health Investments (NASDAQ:CLOV) with a Buy and lowers the price target from $4.1 to $3.7.